| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |